tetano
Editor, Senior Moderator
Seizure. 2020 May 11;79:49-52. doi: 10.1016/j.seizure.2020.05.005. [Epub ahead of print]
Seizures associated with coronavirus infections.
Asadi-Pooya AA[SUP]1[/SUP].
Author information
Abstract
Neurotropic and neuroinvasive capabilities of coronaviruses have been described in humans. Neurological problems found in patients with coronavirus infection include: febrile seizures, convulsions, loss of consciousness, encephalomyelitis, and encephalitis. Coronavirus disease (COVID-19) is caused by SARS-CoV2. In severe cases, patients may develop severe pneumonia, acute respiratory distress syndrome, and acute cardiac injury. While seizures and status epilepticus have not been widely reported in the past five months since the onset of COVID-19 pandemic, patients with COVID-19 may have hypoxia, multiorgan failure, and severe metabolic and electrolyte disarrangements; hence, it is plausible to expect clinical or subclinical acute symptomatic seizures to happen in these patients. One should be prepared to treat seizures appropriately, if they happen in a patient who is already in a critical medical condition and suffers from organ failure.
Copyright ? 2020 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
KEYWORDS:
COVID-19; Coronavirus; Epilepsy; Seizure
PMID:32416567DOI:10.1016/j.seizure.2020.05.005
Seizures associated with coronavirus infections.
Asadi-Pooya AA[SUP]1[/SUP].
Author information
Abstract
Neurotropic and neuroinvasive capabilities of coronaviruses have been described in humans. Neurological problems found in patients with coronavirus infection include: febrile seizures, convulsions, loss of consciousness, encephalomyelitis, and encephalitis. Coronavirus disease (COVID-19) is caused by SARS-CoV2. In severe cases, patients may develop severe pneumonia, acute respiratory distress syndrome, and acute cardiac injury. While seizures and status epilepticus have not been widely reported in the past five months since the onset of COVID-19 pandemic, patients with COVID-19 may have hypoxia, multiorgan failure, and severe metabolic and electrolyte disarrangements; hence, it is plausible to expect clinical or subclinical acute symptomatic seizures to happen in these patients. One should be prepared to treat seizures appropriately, if they happen in a patient who is already in a critical medical condition and suffers from organ failure.
Copyright ? 2020 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
KEYWORDS:
COVID-19; Coronavirus; Epilepsy; Seizure
PMID:32416567DOI:10.1016/j.seizure.2020.05.005